578
Views
13
CrossRef citations to date
0
Altmetric
Review

Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development

, , , &
Pages 269-277 | Received 14 Nov 2016, Accepted 13 Jan 2017, Published online: 01 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Bianca Raffaelli, Heike Israel, Lars Neeb & Uwe Reuter. (2017) The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opinion on Pharmacotherapy 18:13, pages 1409-1415.
Read now

Articles from other publishers (11)

Jo Sourbron & Lieven Lagae. (2022) Serotonin receptors in epilepsy: Novel treatment targets?. Epilepsia Open 7:2, pages 231-246.
Crossref
Fariba Karimzadeh, Fahime Zavvari, Atousa Janzadeh, Negin Mojarad, Zeinab Ghorbani & Mansoureh Togha. (2022) Evaluating Plasma and Brain TRPV1 Channels in the Animal Model of Episodic and Chronic Migraine: The Possible Role of Somatosensory Cortex TRPV1 in Migraine Transformation. Archives of Neuroscience 9:1.
Crossref
Alizée Arnoux, Estelle Ayme-Dietrich, Stéphane Dieterle, Marc-Antoine Goy, Stephan Schann, Mélanie Frauli, Laurent Monassier & Luc Dupuis. (2021) Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis. Scientific Reports 11:1.
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Filip Jovanovic, Kenneth D. Candido & Nebojsa Nick Knezevic. (2020) The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents. International Journal of Molecular Sciences 21:17, pages 6045.
Crossref
Joanna Sniecikowska, Adrian Newman-Tancredi & Marcin Kolaczkowski. (2019) From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery. Current Topics in Medicinal Chemistry 19:26, pages 2393-2420.
Crossref
Lei Wang, Jie Shen, Xin-Ting Cai, Wei-Wei Tao, Ya-Di Wan, Dong-Lin Li, Xiu-Xiu Tan & Yu Wang. (2019) Ventrolateral Periaqueductal Gray Matter Neurochemical Lesion Facilitates Epileptogenesis and Enhances Pain Sensitivity in Epileptic Rats. Neuroscience 411, pages 105-118.
Crossref
Lisa Gfrerer, John H. Hulsen, Matthew D. McLeod, Eric J. Wright & William G. Austen. (2019) Migraine Surgery. Annals of Surgery 269:5, pages 994-999.
Crossref
Mads C. J. Barloese. (2017) The pathophysiology of the trigeminal autonomic cephalalgias, with clinical implications. Clinical Autonomic Research 28:3, pages 315-324.
Crossref
Marta Vila-Pueyo. (2018) Targeted 5-HT1F Therapies for Migraine. Neurotherapeutics 15:2, pages 291-303.
Crossref
Steven C. Wyler, Caleb C. Lord, Syann Lee, Joel K. Elmquist & Chen Liu. (2017) Serotonergic Control of Metabolic Homeostasis. Frontiers in Cellular Neuroscience 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.